Does the neuroprotective agent erythropoietin amplify diffuse axonal injury in its early stages?
Tubbs
R Shane
RS
Shoja
Mohammadali M
MM
Jamshidi
Masoud
M
Shokouhi
Ghaffar
G
D000818:Animals; D001369:Axons / Q000187:drug effects*; D001921:Brain / Q000473:pathology; D002118:Calcium / Q000737:chemistry; D015220:Calcium Channels / Q000378:metabolism; D049109:Cell Proliferation; D020833:Diffuse Axonal Injury / Q000378:metabolism / Q000473:pathology*; D004921:Erythropoietin / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation; D009553:Nimodipine / Q000494:pharmacology; D012964:Sodium / Q000737:chemistry; D013116:Spinal Cord / Q000473:pathology
D015220:Calcium Channels; D004921:Erythropoietin; D009553:Nimodipine; D012964:Sodium; D002118:Calcium